Atlas Trials

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

Clinical trial NCT03302897 · COMPLETED

Trial details

NCT number
NCT03302897
Sponsor
Access to Advanced Health Institute (AAHI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leprosy
Start date
2017-10-02
Primary completion
2019-03-05
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.